{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T18:09:52Z","timestamp":1791828592637,"version":"4.3.4"},"reference-count":18,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,2,6]],"date-time":"2026-02-06T00:00:00Z","timestamp":1770336000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,3,10]],"date-time":"2026-03-10T00:00:00Z","timestamp":1773100800000},"content-version":"vor","delay-in-days":32,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Orphanet J Rare Dis"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Hepatic adenoma is a serious complication of glycogen storage disease, particularly types I and III. However, noninvasive predictors of adenoma presence and progression for use in clinical practice remain limited. In this retrospective study, we included 93 patients with genetically confirmed glycogen storage disease who underwent liver ultrasonography, FibroScan, shear wave elastography, and routine biochemical testing between December 2020 and March 2025. Patients with and without hepatic adenoma were compared to identify discriminative variables, which were used to construct a logistic regression model. Patients with serial imaging data were assessed for changes in adenoma size and clinical parameters.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Of the 93 patients included, 13 (14%) had hepatic adenomas. Age, gamma-glutamyl transferase levels, triglyceride levels, liver stiffness measured by FibroScan, and total cholesterol levels were significantly elevated in patients with adenoma compared to those without adenoma (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt;\u20090.05). A logistic regression model combining age, gamma-glutamyl transferase, triglycerides, liver stiffness as measured by FibroScan, total cholesterol, and liver stiffness as measured by shear wave elastography achieved an area under the curve of 0.87. Adenoma progression was accompanied by changes in gamma-glutamyl transferase levels and the FibroScan Controlled Attenuation Parameter. The simplified thresholds of gamma-glutamyl transferase\u2009&gt;\u200960 IU\/L, triglycerides\u2009&gt;\u2009300\u00a0mg\/dL, liver stiffness by FibroScan\u2009&gt;\u20096.0, FibroScan Controlled Attenuation Parameter\u2009&gt;\u2009280 dB\/m, and total cholesterol\u2009&gt;\u2009220\u00a0mg\/dL were determined from group comparisons and the logistic regression model.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>The findings suggest that routine biochemical markers, together with selected elastographic parameters for supportive assessment, can aid in the detection and risk stratification of hepatic adenomas in patients with glycogen storage disease. The use of data-derived clinical thresholds may help guide surveillance strategies and facilitate earlier identification of patients potentially at increased risk.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s13023-026-04239-z","type":"journal-article","created":{"date-parts":[[2026,2,6]],"date-time":"2026-02-06T09:38:45Z","timestamp":1770370725000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Correlation of biochemical and imaging markers with hepatic adenoma in patients with glycogen storage disease: a retrospective single-center study"],"prefix":"10.1186","volume":"21","author":[{"given":"Jhii-Hyun","family":"Ahn","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seung Whan","family":"Cha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1712-2138","authenticated-orcid":false,"given":"Yunkoo","family":"Kang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,2,6]]},"reference":[{"key":"4239_CR1","volume-title":"Glycogen storage disease","author":"WL Stone","year":"2025","unstructured":"Stone WL, John TA, Anastasopoulou C, Basit H, Adil A. Glycogen storage disease. Treasure Island: StatPearls; 2025."},{"key":"4239_CR2","doi-asserted-by":"publisher","first-page":"e5","DOI":"10.3346\/jkms.2020.35.e5","volume":"35","author":"HJ Jang","year":"2020","unstructured":"Jang HJ, Yang HR, Ko JS, Moon JS, Chang JY, Seo JK. Development of hepatocellular carcinoma in patients with glycogen storage disease: a single center retrospective study. J Korean Med Sci. 2020;35:e5. https:\/\/doi.org\/10.3346\/jkms.2020.35.e5.","journal-title":"J Korean Med Sci"},{"key":"4239_CR3","doi-asserted-by":"publisher","unstructured":"Lee PJ. Glycogen storage disease type I: pathophysiology of liver adenomas. Eur J Pediatr. 2002;161(Suppl 1). https:\/\/doi.org\/10.1007\/s00431-002-1002-0. S46-9.","DOI":"10.1007\/s00431-002-1002-0"},{"key":"4239_CR4","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1186\/s13023-025-03605-7","volume":"20","author":"JH Ahn","year":"2025","unstructured":"Ahn JH, Jeong YW, Choi YB, Kang Y. Efficacy of magnetic resonance imaging in managing glycogen storage disease. Orphanet J Rare Dis. 2025;20:144. https:\/\/doi.org\/10.1186\/s13023-025-03605-7.","journal-title":"Orphanet J Rare Dis"},{"key":"4239_CR5","doi-asserted-by":"publisher","first-page":"1303","DOI":"10.7150\/thno.18650","volume":"7","author":"RMS Sigrist","year":"2017","unstructured":"Sigrist RMS, Liau J, Kaffas AE, Chammas MC, Willmann JK. Ultrasound elastography: review of techniques and clinical applications. Theranostics. 2017;7:1303\u201329. https:\/\/doi.org\/10.7150\/thno.18650.","journal-title":"Theranostics"},{"issue":"Suppl 1","key":"4239_CR6","doi-asserted-by":"publisher","first-page":"S20","DOI":"10.1007\/s00431-002-0999-4","volume":"161","author":"JP Rake","year":"2002","unstructured":"Rake JP, Visser G, Labrune P, Leonard JV, Ullrich K, Smit GPA. Glycogen storage disease type I: diagnosis, management, clinical course and outcome. Results of the European study on glycogen storage disease type I (ESGSD I). Eur J Pediatr. 2002;161(Suppl 1):S20\u201334. https:\/\/doi.org\/10.1007\/s00431-002-0999-4.","journal-title":"Eur J Pediatr"},{"key":"4239_CR7","doi-asserted-by":"publisher","first-page":"e1","DOI":"10.1038\/gim.2014.128","volume":"16","author":"PS Kishnani","year":"2014","unstructured":"Kishnani PS, Austin SL, Abdenur JE, Arn P, Bali DS, Boney A, et al. Diagnosis and management of glycogen storage disease type I: a practice guideline of the American college of medical genetics and genomics. Genet Med. 2014;16:e1. https:\/\/doi.org\/10.1038\/gim.2014.128.","journal-title":"Genet Med"},{"key":"4239_CR8","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1097\/00005176-199703000-00008","volume":"24","author":"P Labrune","year":"1997","unstructured":"Labrune P, Trioche P, Duvaltier I, Chevalier P, Odi\u00e8vre M. Hepatocellular adenomas in glycogen storage disease type I and III: a series of 43 patients and review of the literature. J Pediatr Gastroenterol Nutr. 1997;24:276\u20139. https:\/\/doi.org\/10.1097\/00005176-199703000-00008.","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"4239_CR9","doi-asserted-by":"publisher","first-page":"398","DOI":"10.1016\/j.ymgme.2007.10.134","volume":"93","author":"M Di Rocco","year":"2008","unstructured":"Di Rocco M, Calevo MG, Taro\u2019 M, Melis D, Allegri AEM, Parenti G. Hepatocellular adenoma and metabolic balance in patients with type Ia glycogen storage disease. Mol Genet Metab. 2008;93:398\u2013402. https:\/\/doi.org\/10.1016\/j.ymgme.2007.10.134.","journal-title":"Mol Genet Metab"},{"key":"4239_CR10","doi-asserted-by":"publisher","first-page":"1717","DOI":"10.1053\/j.gastro.2019.01.042","volume":"156","author":"PJ Eddowes","year":"2019","unstructured":"Eddowes PJ, Sasso M, Allison M, Tsochatzis E, Anstee QM, Sheridan D, et al. Accuracy of fibroscan controlled Attenuation parameter and liver stiffness measurement in assessing steatosis and fibrosis in patients with nonalcoholic fatty liver disease. Gastroenterology. 2019;156:1717\u201330. https:\/\/doi.org\/10.1053\/j.gastro.2019.01.042.","journal-title":"Gastroenterology"},{"key":"4239_CR11","doi-asserted-by":"publisher","first-page":"462","DOI":"10.1007\/BF00710057","volume":"18","author":"PJ Lee","year":"1995","unstructured":"Lee PJ, Leonard JV. The hepatic glycogen storage diseases\u2014problems beyond childhood. J Inherit Metab Dis. 1995;18:462\u201372. https:\/\/doi.org\/10.1007\/BF00710057.","journal-title":"J Inherit Metab Dis"},{"issue":"Suppl 1","key":"4239_CR12","doi-asserted-by":"publisher","first-page":"S112","DOI":"10.1007\/s00431-002-1016-7","volume":"161","author":"JP Rake","year":"2002","unstructured":"Rake JP, Visser G, Labrune P, Leonard JV, Ullrich K, Smit GP, et al. Guidelines for management of glycogen storage disease type I \u2013 European study on glycogen storage disease type I (ESGSD I). Eur J Pediatr. 2002;161(Suppl 1):S112\u20139. https:\/\/doi.org\/10.1007\/s00431-002-1016-7.","journal-title":"Eur J Pediatr"},{"key":"4239_CR13","doi-asserted-by":"publisher","first-page":"175628482211406","DOI":"10.1177\/17562848221140657","volume":"15","author":"G Ferraioli","year":"2022","unstructured":"Ferraioli G, Roccarina D. Update on the role of elastography in liver disease. Ther Adv Gastroenterol. 2022;15:17562848221140657. https:\/\/doi.org\/10.1177\/17562848221140657.","journal-title":"Ther Adv Gastroenterol"},{"key":"4239_CR14","doi-asserted-by":"publisher","first-page":"4407","DOI":"10.1007\/s10620-023-08143-5","volume":"68","author":"HH Bui","year":"2023","unstructured":"Bui HH, Nguyen STB, Phan ST, Nguyen KM, Nguyen CD. Evaluating M2BPGi as a marker for liver fibrosis in patients with chronic hepatitis B. Dig Dis Sci. 2023;68:4407\u201317. https:\/\/doi.org\/10.1007\/s10620-023-08143-5.","journal-title":"Dig Dis Sci"},{"key":"4239_CR15","doi-asserted-by":"publisher","first-page":"302","DOI":"10.3343\/alm.2021.41.3.302","volume":"41","author":"SY Jang","year":"2021","unstructured":"Jang SY, Tak WY, Park SY, Kweon YO, Lee YR, Kim G, et al. Diagnostic efficacy of serum Mac-2 binding protein glycosylation isomer and other markers for liver fibrosis in non-alcoholic fatty liver diseases. Ann Lab Med. 2021;41:302\u20139. https:\/\/doi.org\/10.3343\/alm.2021.41.3.302.","journal-title":"Ann Lab Med"},{"key":"4239_CR16","doi-asserted-by":"publisher","first-page":"e165","DOI":"10.3346\/jkms.2019.34.e165","volume":"34","author":"YD Kwon","year":"2019","unstructured":"Kwon YD, Ko KO, Lim JW, Cheon EJ, Song YH, Yoon JM. Usefulness of transient elastography for non-invasive diagnosis of liver fibrosis in pediatric non-alcoholic steatohepatitis. J Korean Med Sci. 2019;34:e165. https:\/\/doi.org\/10.3346\/jkms.2019.34.e165.","journal-title":"J Korean Med Sci"},{"key":"4239_CR17","doi-asserted-by":"publisher","first-page":"goae024","DOI":"10.1093\/gastro\/goae024","volume":"12","author":"JCT Lai","year":"2024","unstructured":"Lai JCT, Liang LY, Wong GLH. Noninvasive tests for liver fibrosis in 2024: are there different scales for different diseases? Gastroenterol Rep (Oxf). 2024;12:goae024. https:\/\/doi.org\/10.1093\/gastro\/goae024.","journal-title":"Gastroenterol Rep (Oxf)"},{"key":"4239_CR18","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1016\/j.jhep.2021.05.025","volume":"75","author":"European Association for the Study of the Liver","year":"2021","unstructured":"European Association for the Study of the Liver. EASL clinical practice guidelines on non-invasive tests for evaluation of liver disease severity and prognosis \u2013 2021 update. J Hepatol. 2021;75:659\u201389. https:\/\/doi.org\/10.1016\/j.jhep.2021.05.025.","journal-title":"J Hepatol"}],"container-title":["Orphanet Journal of Rare Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13023-026-04239-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13023-026-04239-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13023-026-04239-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T17:39:56Z","timestamp":1781631596000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s13023-026-04239-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,6]]},"references-count":18,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["4239"],"URL":"https:\/\/doi.org\/10.1186\/s13023-026-04239-z","relation":{},"ISSN":["1750-1172"],"issn-type":[{"value":"1750-1172","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,6]]},"assertion":[{"value":"12 June 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 January 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 February 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"His study was conducted in accordance with the Declaration of Helsinki and was approved by the Institutional Review Board of Yonsei University Wonju College of Medicine (No. CR325018). The requirement for informed consent was waived by the Institutional Review Board due to the retrospective nature of the study and the use of anonymized data.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"95"}}